Compile Data Set for Download or QSAR
maximum 50k data
Found 18 Enz. Inhib. hit(s) with all data for entry = 9697
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482293(US10919843, Compound II)
Affinity DataEC50:  4.30E+3nMAssay Description:NIH3T3-EPO-luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482301(US10919843, Compound X)
Affinity DataEC50:  1.20E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482295(US10919843, Compound IV)
Affinity DataEC50:  3.20E+3nMAssay Description:NIH3T3-EPO-luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482296(US10919843, Compound V)
Affinity DataEC50:  1.80E+3nMAssay Description:NIH3T3-EPO-luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482297(US10919843, Compound VI)
Affinity DataEC50:  2.80E+3nMAssay Description:NIH3T3-EPO-luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482298(US10919843, Compound VII)
Affinity DataEC50:  2.90E+3nMAssay Description:NIH3T3-EPO-luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482299(US10919843, Compound VIII)
Affinity DataEC50:  2.60E+3nMAssay Description:NIH3T3-EPO-luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482300(US10919843, Compound IX)
Affinity DataEC50:  2.50E+3nMAssay Description:NIH3T3-EPO-luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482301(US10919843, Compound X)
Affinity DataEC50:  3.30E+3nMAssay Description:NIH3T3-EPO-luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482293(US10919843, Compound II)
Affinity DataEC50:  3.20E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482294(US10919843, Compound III)
Affinity DataEC50:  1.70E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482295(US10919843, Compound IV)
Affinity DataEC50:  1.60E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482296(US10919843, Compound V)
Affinity DataEC50:  1.90E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482297(US10919843, Compound VI)
Affinity DataEC50:  4.00E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482298(US10919843, Compound VII)
Affinity DataEC50:  5.50E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482299(US10919843, Compound VIII)
Affinity DataEC50:  1.40E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482300(US10919843, Compound IX)
Affinity DataEC50:  1.40E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Emerald Health Pharmaceuticals

US Patent
LigandPNGBDBM482294(US10919843, Compound III)
Affinity DataEC50:  3.60E+3nMAssay Description:NIH3T3-EPO-luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent